Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8951 |
High Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.8819 |
High Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.8601 |
High Similarity |
NPD2800 |
Approved |
0.8591 |
High Similarity |
NPD7411 |
Suspended |
0.8571 |
High Similarity |
NPD6651 |
Approved |
0.8533 |
High Similarity |
NPD6801 |
Discontinued |
0.8462 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.8462 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.8431 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.8403 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.8403 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.8369 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.8369 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.8355 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.8355 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8322 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.8311 |
Intermediate Similarity |
NPD2534 |
Approved |
0.8311 |
Intermediate Similarity |
NPD2533 |
Approved |
0.8311 |
Intermediate Similarity |
NPD2532 |
Approved |
0.8301 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.8298 |
Intermediate Similarity |
NPD1240 |
Approved |
0.8288 |
Intermediate Similarity |
NPD3750 |
Approved |
0.8264 |
Intermediate Similarity |
NPD2796 |
Approved |
0.8243 |
Intermediate Similarity |
NPD6799 |
Approved |
0.8235 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8219 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.8219 |
Intermediate Similarity |
NPD1243 |
Approved |
0.8182 |
Intermediate Similarity |
NPD1607 |
Approved |
0.8158 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.8129 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.8121 |
Intermediate Similarity |
NPD1511 |
Approved |
0.8113 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.8079 |
Intermediate Similarity |
NPD920 |
Approved |
0.8077 |
Intermediate Similarity |
NPD3749 |
Approved |
0.8069 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.8039 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.8028 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.8028 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.8013 |
Intermediate Similarity |
NPD1512 |
Approved |
0.8 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7962 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7961 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7949 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7945 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7935 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7933 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7919 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7919 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7902 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7899 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7891 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7891 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7853 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7853 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7842 |
Intermediate Similarity |
NPD9717 |
Approved |
0.784 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7829 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7829 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7812 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7801 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7801 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7764 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7758 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7703 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7673 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7665 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7654 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7654 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7651 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7651 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7628 |
Intermediate Similarity |
NPD3226 |
Approved |
0.761 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7606 |
Intermediate Similarity |
NPD3225 |
Approved |
0.76 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7584 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.7578 |
Intermediate Similarity |
NPD919 |
Approved |
0.7576 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7562 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7561 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7561 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7561 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7552 |
Intermediate Similarity |
NPD3266 |
Approved |
0.7552 |
Intermediate Similarity |
NPD3267 |
Approved |
0.7534 |
Intermediate Similarity |
NPD1296 |
Phase 2 |
0.7531 |
Intermediate Similarity |
NPD5494 |
Approved |
0.753 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7517 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.75 |
Intermediate Similarity |
NPD2798 |
Approved |
0.75 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7485 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7485 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7483 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7456 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7451 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.744 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7425 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7421 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7415 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7396 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7358 |
Intermediate Similarity |
NPD6585 |
Discontinued |
0.7357 |
Intermediate Similarity |
NPD9545 |
Approved |
0.7353 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7351 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7345 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7343 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7338 |
Intermediate Similarity |
NPD9493 |
Approved |
0.7329 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7315 |
Intermediate Similarity |
NPD4307 |
Phase 2 |
0.7297 |
Intermediate Similarity |
NPD411 |
Approved |
0.729 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7284 |
Intermediate Similarity |
NPD4288 |
Approved |
0.7279 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7273 |
Intermediate Similarity |
NPD2654 |
Approved |
0.7267 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7234 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7232 |
Intermediate Similarity |
NPD4360 |
Phase 2 |
0.7232 |
Intermediate Similarity |
NPD4363 |
Phase 3 |
0.7215 |
Intermediate Similarity |
NPD5049 |
Phase 3 |
0.7205 |
Intermediate Similarity |
NPD5889 |
Approved |
0.7205 |
Intermediate Similarity |
NPD5890 |
Approved |
0.72 |
Intermediate Similarity |
NPD4287 |
Approved |
0.72 |
Intermediate Similarity |
NPD943 |
Approved |
0.7197 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7191 |
Intermediate Similarity |
NPD4362 |
Clinical (unspecified phase) |
0.7191 |
Intermediate Similarity |
NPD4361 |
Phase 2 |
0.719 |
Intermediate Similarity |
NPD5406 |
Approved |
0.719 |
Intermediate Similarity |
NPD5405 |
Approved |
0.719 |
Intermediate Similarity |
NPD5408 |
Approved |
0.719 |
Intermediate Similarity |
NPD5404 |
Approved |
0.7188 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7181 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7176 |
Intermediate Similarity |
NPD1729 |
Discontinued |
0.7172 |
Intermediate Similarity |
NPD4749 |
Approved |
0.717 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7169 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7162 |
Intermediate Similarity |
NPD1008 |
Clinical (unspecified phase) |
0.7153 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7153 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.7152 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7152 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7152 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7143 |
Intermediate Similarity |
NPD6005 |
Phase 3 |
0.7143 |
Intermediate Similarity |
NPD6006 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD1019 |
Discontinued |
0.7143 |
Intermediate Similarity |
NPD6004 |
Phase 3 |
0.7143 |
Intermediate Similarity |
NPD6002 |
Phase 3 |
0.7143 |
Intermediate Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD6003 |
Clinical (unspecified phase) |
0.7135 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7133 |
Intermediate Similarity |
NPD17 |
Approved |
0.7126 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7115 |
Intermediate Similarity |
NPD7003 |
Approved |
0.7114 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7081 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7075 |
Intermediate Similarity |
NPD1164 |
Approved |
0.707 |
Intermediate Similarity |
NPD2354 |
Approved |
0.7067 |
Intermediate Similarity |
NPD1699 |
Clinical (unspecified phase) |
0.7067 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7051 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7041 |
Intermediate Similarity |
NPD7784 |
Clinical (unspecified phase) |
0.7041 |
Intermediate Similarity |
NPD2403 |
Approved |
0.7039 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7022 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.6994 |
Remote Similarity |
NPD6104 |
Discontinued |
0.6986 |
Remote Similarity |
NPD1481 |
Phase 2 |
0.6982 |
Remote Similarity |
NPD3926 |
Phase 2 |
0.6981 |
Remote Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.6964 |
Remote Similarity |
NPD7199 |
Phase 2 |
0.6954 |
Remote Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.6944 |
Remote Similarity |
NPD4196 |
Clinical (unspecified phase) |
0.6928 |
Remote Similarity |
NPD6355 |
Discontinued |
0.6923 |
Remote Similarity |
NPD2355 |
Clinical (unspecified phase) |
0.6923 |
Remote Similarity |
NPD2353 |
Approved |
0.6918 |
Remote Similarity |
NPD1535 |
Discovery |
0.6914 |
Remote Similarity |
NPD8312 |
Approved |
0.6914 |
Remote Similarity |
NPD8313 |
Approved |
0.6898 |
Remote Similarity |
NPD7584 |
Approved |
0.6893 |
Remote Similarity |
NPD8434 |
Phase 2 |
0.6884 |
Remote Similarity |
NPD74 |
Approved |
0.6884 |
Remote Similarity |
NPD9266 |
Approved |
0.6882 |
Remote Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.6879 |
Remote Similarity |
NPD1241 |
Discontinued |
0.6875 |
Remote Similarity |
NPD1894 |
Discontinued |
0.6871 |
Remote Similarity |
NPD3972 |
Approved |
0.6863 |
Remote Similarity |
NPD4060 |
Phase 1 |
0.686 |
Remote Similarity |
NPD7893 |
Clinical (unspecified phase) |
0.6859 |
Remote Similarity |
NPD4477 |
Approved |
0.6859 |
Remote Similarity |
NPD4476 |
Approved |
0.6855 |
Remote Similarity |
NPD3887 |
Approved |
0.6829 |
Remote Similarity |
NPD6502 |
Phase 2 |
0.6821 |
Remote Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.6812 |
Remote Similarity |
NPD9265 |
Clinical (unspecified phase) |
0.6812 |
Remote Similarity |
NPD9264 |
Approved |
0.6812 |
Remote Similarity |
NPD9263 |
Approved |
0.6812 |
Remote Similarity |
NPD9267 |
Approved |
0.6809 |
Remote Similarity |
NPD5535 |
Approved |
0.6803 |
Remote Similarity |
NPD1201 |
Approved |
0.6797 |
Remote Similarity |
NPD6233 |
Phase 2 |
0.6795 |
Remote Similarity |
NPD651 |
Clinical (unspecified phase) |
0.679
|
Remote Similarity |
NPD6273 |
Approved |